๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Argininosuccinate synthetase activity in cultured human lymphocytes

โœ Scribed by Oksana Lockridge; Elaine B. Spector; Arthur D. Bloom


Publisher
Springer
Year
1977
Tongue
English
Weight
655 KB
Volume
15
Category
Article
ISSN
0006-2928

No coin nor oath required. For personal study only.

โœฆ Synopsis


The activity of argininosuccinate synthetase (E.C. 6.3.4.5), a urea cycle enzyme, was measured in cultured human lymphocytes using a new radioactive assay. Control cells had a maximum specific activity of 15.7 +/- 8.7 nmoles per hour per milligram of protein and an apparent Km for citrulline of 2 X 10(-4) M, whereas cells derived from a patient with citrullinemia had no detectable activity. A nutritional variant, selected out of the citrullinemic lymphocyte population by ability to grow in citrulline, had a maximum specific activity of 10.7 +/- 3.8 nmoles/hr/mg and an apparent Km for citrulline of 2 X 10(-2) M. These measurements confirm the observation that citrullinemia is associated with a defect in argininosuccinate synthetase activity and provide further evidence that citrullinemia is expressed in cultured lymphocytes. The emergence of a nutritional variant with a partial defect in argininosuccinate synthetase enzyme suggests that this citrullinemic patient has a heterogeneous population of cells, some totally defective and others only partially defective in argininosuccinate synthetase. The new activity assay is described in detail.


๐Ÿ“œ SIMILAR VOLUMES


Mutations and polymorphisms in the human
โœ Katharina Engel; Wolfgang Hรถhne; Johannes Hรคberle ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 399 KB

Citrullinemia type I is an autosomal recessive disorder that is caused by a deficiency of the urea cycle enzyme argininosuccinate synthetase (ASS1). Deficiency of ASS1 shows various clinical manifestations encompassing severely affected patients with fatal neonatal hyperammonemia as well as asymptom

Aberrant regulation of argininosuccinate
โœ Peter W. Szlosarek; Matthew J. Grimshaw; George D. Wilbanks; Thorsten Hagemann; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 321 KB

## Abstract The proโ€inflammatory cytokine, tumour necrosis factorโ€ฮฑ, TNFโ€ฮฑ, is dysregulated in malignant compared with normal ovarian surface epithelium (OSE). Several epidemiological studies have associated inflammation with ovarian tumorigenesis, with TNFโ€ฮฑ playing a key role in modulating invasi